Kubota Pharmaceutical (KBBTF) Inactive 10-Q2015 Q1 Quarterly report

Filed: 14 May 15, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Good

New words: abroad, accelerated, accrual, affiliated, borrowing, carryforward, COBRA, composition, context, creation, Danse, deemed, default, degenerative, difficulty, disability, disruption, disruptive, Edward, Eisaku, equipment, Europe, European, exhaust, fully, Gebhart, goal, grossed, guide, hypothetical, iii, important, Incentive, incremental, issuer, iv, John, Jumpstart, Kitao, lampalizumab, larger, leveraging, Mita, Mitsubishi, modification, monthly, Morgan, Nakamura, ophthalmology, pertaining, pool, preclinical, preservation, preserve, pro, proposed, rata, removed, removing, repurchase, Robert, Roche, salary, Shiro, single, speculative, Stanley, Steve, Steven, structured, sum, Takeuchi, Tarr, temporary, therapeutic, thereof, tissue, tolerable, UFJ, unconsolidated, unvested, vested, vesting, Yoshitaka

Removed: acted, actively, activity, adenosine, agonist, announced, assessing, Assessment, assume, attributable, building, capability, certificate, charge, collaborate, commencing, commitment, comparing, consolidated, contracting, cooperative, creating, critical, Description, determining, direct, ending, enrollment, establishing, expanding, force, formal, fulfilled, Genentech, harder, hiring, holder, inception, incorporation, Japanese, job, Kresel, lessen, light, lower, minimize, Mother, multicenter, municipal, negotiating, NOL, noncurrent, occurred, oral, outplacement, oxidative, par, participate, participating, persuade, Peter, pigmentosa, placebo, point, power, preference, prematurity, prepare, productivity, prospective, protecting, realize, recently, receptor, reducing, reduction, refer, representing, request, restated, restricting, restructure, restructuring, retaining, retina, root, secure, Stargardt, subtracted, supply, suspended, therapy, toxic, Undistributed, Unforeseen, utilizing, workforce

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

KBBTF similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Ryo Kubota, M.D., Ph.D., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge, the quarterly report of Acucela Inc. on Form 10-Q for the three months ended March 31, 2015 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as applicable, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Acucela Inc. for the periods presented therein.



Date:	May 14, 2015	/s/ Ryo Kubota, M.D., Ph.D.
		Chairman, President and Chief Executive Officer
		(Principal Executive Officer)